• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VENUSA DE MEXICO S.A. DE C.V. TACTICATH¿ QUARTZ CONTACT FORCE ABLATION CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VENUSA DE MEXICO S.A. DE C.V. TACTICATH¿ QUARTZ CONTACT FORCE ABLATION CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Paralysis (1997); Cardiac Perforation (2513); Pseudoaneurysm (2605)
Event Type  Injury  
Manufacturer Narrative
The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported cardiac perforation, pseudoaneurysm or paralysis could not be conclusively determined.Per the ifu, cardiac perforation is a known risk during the use of this device.Further information regarding the event was requested but not received.
 
Event Description
Related manufacturer reference: 2030404-2020-00029, 3005334138-2020-00169.The following was published in the international journal of cardiovascular imaging in an article titled ¿combined use of electro-anatomic mapping system and intracardiac echocardiography to achieve zero-fluoroscopy catheter ablation for treatment of paroxysmal atrial fibrillation: a single centre experience" by jan, matev¿ , et al., 11 november 2019."we included 144 consecutive patients (69% males, age 60 ± 10 years, bmi 29 ± 4,6) referred for ca of symptomatic paroxysmal af.All procedures were performed only with eam system and ice.No fluoroscopy was used.Once the transseptal access was obtained a 10 or 20-polar circular mapping catheter ( afocus ii¿; abbott, abbott park, (b)(4), usa) and an irrigated tip ablation catheter (tacticath¿, flexability¿; both abbott, abbott park, (b)(4), usa) were placed inside the la and the 3d eam system was initialized.One patient had cardiac tamponade immediately after double transseptal puncture, which resulted in termination of the procedure.A possible reason for tamponade could be accidental puncture of the contralateral la wall in a patient with only slightly enlarged la and a floppy interatrial septum.Two patients had a pseudoaneurysm of the right femoral artery that required surgical intervention.Four patients had a peri-procedural pericardial effusion, which resolved spontaneously without any treatment.All four pericardial effusions manifested shortly after the procedure, which implies they were not a consequence of transseptal puncture, but rather of transmural rf lesions.One patient had prolonged paresis of the right diaphragm, which eventually resolved after 6 months.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TACTICATH¿ QUARTZ CONTACT FORCE ABLATION CATHETER
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
VENUSA DE MEXICO S.A. DE C.V.
calle hertz 1525-6
parque industrial j. bermudez
ciudad juarez, chihuahua 32470
MX  32470
Manufacturer (Section G)
VENUSA DE MEXICO S.A. DE C.V. (JUAREZ)
calle hertz 1525-6
parque industrial j. bermudez
ciudad juarez, chihuahua 32470
MX   32470
Manufacturer Contact
stephanie o' sullivan
5050 nathan lane north
plymouth, MN 55442
6517565400
MDR Report Key10051509
MDR Text Key190791434
Report Number9680001-2020-00023
Device Sequence Number1
Product Code OAE
Combination Product (y/n)N
Reporter Country CodeSI
PMA/PMN Number
P130026
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 05/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 04/20/2020
Initial Date FDA Received05/13/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
FLEXABILITY ABLATION CATHETER; INQUIRY¿ AFOCUS¿ DIAGNOSTIC CATHETER
Patient Outcome(s) Other;
-
-